These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5169130)

  • 1. [Biopharmaceutical studies on indomethacin. II. Mechanism of intestinal absorption of indomethacin in rat in vitro and availability of micronized powder after oral administration to man].
    Fuwa T; Iga T; Hanano M; Nogami H; Kashima M
    Yakugaku Zasshi; 1971 Nov; 91(11):1223-7. PubMed ID: 5169130
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioavailability of indomethacin in man.
    Baer JE; Hucker HB; Duggan DE
    Ann Clin Res; 1974; 6(0):suppl 11:44-7. PubMed ID: 4211834
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study.
    Bours MJ; Bos HJ; Meddings JB; Brummer RJ; van den Brandt PA; Dagnelie PC
    BMC Gastroenterol; 2007 Jun; 7():23. PubMed ID: 17578566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biopharmaceutical studies on indomethacin. I. Analysis of concentration time course in rabbit plasma after intravenous administration and relationship between dosage form and absorption after intraduodenal administration].
    Moriyama M; Saito M; Awazu S; Hanano M; Nogami H
    Yakugaku Zasshi; 1971 Nov; 91(11):1217-22. PubMed ID: 5169129
    [No Abstract]   [Full Text] [Related]  

  • 5. Biopharmaceutical evaluation of 'Osmosin'.
    Rogers JD
    Curr Med Res Opin; 1983; 8 Suppl 2():38-54. PubMed ID: 6851625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on indomethacin acute toxicity and absorption.
    Naciazek-Wieniawska A; Wilczyńska-Wojtulewicz I
    Pol J Pharmacol Pharm; 1975; 27(3):245-50. PubMed ID: 1144203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation of capsules of microencapsulated indomethacin and their bioavailability in rabbits].
    Lu B; Zhang L; Deng YH
    Hua Xi Yi Ke Da Xue Xue Bao; 1986 Dec; 17(4):328-31. PubMed ID: 3570271
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of sustained release on the pharmacokinetic profile of indomethacin in man.
    Yeh KC; Berger ET; Breault GO; Lei BW; McMahon FG
    Biopharm Drug Dispos; 1982; 3(3):219-30. PubMed ID: 7139063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of indomethacin capsules in humans. (I): Bioavailability and effects of gastric acidity.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):469-74. PubMed ID: 4055157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of indomethacin in liposomes.
    Stozek T
    Acta Pol Pharm; 1992; 49(4):21-6. PubMed ID: 16092430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jejunal absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(d,l-lactide) and poly(isobutyl-cyanoacrylate) nanocapsules in rats.
    Ammoury N; Fessi H; Devissaguet JP; Dubrasquet M; Benita S
    Pharm Res; 1991 Jan; 8(1):101-5. PubMed ID: 2014197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of indomethacin.
    Alván G; Orme M; Bertilsson L; Ekstrand R; Palmér L
    Clin Pharmacol Ther; 1975 Sep; 18(3):364-73. PubMed ID: 1100305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the entero-hepatic cycle of indomethacin on its metabolism, distribution in tissues and its excretion by rats, dogs and monkeys.
    Yesair DW; Callahan M; Remington L; Kensler CJ
    Biochem Pharmacol; 1970 May; 19(5):1579-90. PubMed ID: 5535185
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of Pluronic gels on the rectal absorption of indomethacin in rabbits.
    Miyazaki S; Nakamura T; Yokouchi C; Takada M
    Chem Pharm Bull (Tokyo); 1987 Mar; 35(3):1243-8. PubMed ID: 3607947
    [No Abstract]   [Full Text] [Related]  

  • 15. Physiologic disposition and metabolic fate of indomethacin analogs. I. 1-p-chlorobenzylidenyl-5-methoxy-2-methylindene-3-acetic acid.
    Hucker HB; Hoffman EA
    J Pharm Sci; 1971 Jul; 60(7):1049-52. PubMed ID: 5115245
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic evaluation of indomethacin nanocapsules.
    Andrieu V; Fessi H; Dubrasquet M; Devissaguet JP; Puisieux F; Benita S
    Drug Des Deliv; 1989 Jun; 4(4):295-302. PubMed ID: 2775449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energy-Dependent Endocytosis is Involved in the Absorption of Indomethacin Nanoparticles in the Small Intestine.
    Ishii M; Fukuoka Y; Deguchi S; Otake H; Tanino T; Nagai N
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of indomethacin capsules in humans (III): Correlation with bioavailability in beagle dogs.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A; Nakata H; Tsutsumi J; Fujita T; Amada I
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):578-84. PubMed ID: 4077308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of pharmacokinetics of indomethacin in man under consideration of bioavailability.
    Hippius M; Reinicke C
    Agents Actions Suppl; 1982; 10():109-17. PubMed ID: 6956211
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioavailability of indomethacin tablets in men volunteers.
    Groth PE; Dunn JM
    Clin Pharm; 1986 Oct; 5(10):820-4. PubMed ID: 3780150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.